Connect with us

Health

COVID-19: Situation worsens in B.C. with 102 new cases – Vancouver Sun

Published

on


Article content

Provincial health officer Dr. Bonnie Henry has warned that B.C.’s COVID-19 curve is starting to worsen, with the possibility of an explosive growth in cases.

On Monday, Henry reported 102 new cases of COVID-19 over the past three days, and no new deaths.

She said there were 253 active cases of the disease in B.C., of which 16 were being treated in hospital (including four in intensive care.)

“We are starting to see an upward bend of our curve,” Henry said. “We do have a possibility of having an explosive growth if we are not careful.” The disease reproductive rate was now higher than one, where one sick person infects more than one other person.

Henry noted that people who had tested positive this month were having a greater numbers of contact with other people compared to cases detected last month. B.C.’s Restart Plan was upgraded to phase three on July 1, allowing more social contacts.

There have been 3,300 cases reported since the first case was identified in late January in a Vancouver resident who had returned from a business trip in Wuhan, China, where the disease originated. There have been 189 deaths.

Let’s block ads! (Why?)



Source link

Continue Reading

Health

speed of COVID-19 vaccine race raises safety concerns

Published

on

BRUSSELS/LONDON (Reuters) – The frenetic race to develop a COVID-19 vaccine has intensified safety concerns about an inoculation, prompting governments and drugmakers to raise awareness to ensure their efforts to beat the coronavirus aren’t derailed by public distrust.

FILE PHOTO: A small bottle labeled with a “Vaccine” sticker stands near a medical syringe in front of displayed “Coronavirus COVID-19” words in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration

There are more than 200 COVID-19 vaccine candidates in development globally, including more than 20 in human clinical trials. U.S. President Donald Trump has vowed to have a shot ready before year’s end, although they typically take 10 years or longer to develop and test for safety and effectiveness.

In the drive to find a potential COVID-19 vaccine “fast is good for politicians,” said Heidi Larson, who leads the Vaccine Confidence Project (VCP), a global surveillance programme on vaccine trust. “But from the public perspective, the general sentiment is: ‘too fast can’t be safe’”, she told Reuters.

Regulators around the world have repeatedly said speed will not compromise safety, as quicker results would stem from conducting in parallel trials that are usually done in sequence.

However, these reassurances have failed to convince many, including in Western countries where scepticism about vaccinations was already growing before the pandemic.

Preliminary results of a survey conducted over the last three months in 19 countries showed that only about 70% of British and U.S. respondents would take a COVID-19 vaccine if available, Scott Ratzan, co-leader of ‘Business Partners to CONVINCE’, told Reuters.

Business Partners to CONVINCE, a U.S./UK initiative that is partly government funded, conducted the survey jointly with VCP and the results were broadly in line with a Reuters/Ipsos poll of the U.S. public in May.

“We just see this distrust growing against science and government,” said Ratzan.

“We need to address legitimate concerns about the rapid pace of development, political over-promises and the risks of vaccination.”

The VCP/Business Partners’ survey, expected to be published in a few weeks, will also show that Chinese participants were the most trusting of vaccines, while Russians were the least so, Ratzan said.

Drugmakers and governments had hoped the scale of the COVID-19 crisis would allay concerns about vaccines, which they see as crucial to defeating the pandemic and enabling economies to fully recover from its impact.

Vaccine hesitancy – or the reluctance or refusal to be vaccinated – is also known as “anti-vax”, a term that is sometimes associated with conspiracy theories when often it simply reflects many people’s concerns about side-effects or industry ethics.

In January 2019 the World Health Organisation named vaccine hesitancy as one of the top 10 global health threats for that year.

TAILORED MESSAGES

In Europe, scepticism among the public was high before the pandemic due to a range of factors including negative coverage of pharmaceutical companies as well as false theories including suggested links between childhood immunisations and autism.

Only 70% of French people considered vaccines safe in a 2018 survey commissioned by the European Union executive. The EU average was 82%, but trust fell to 68% for the shot against seasonal flu.

The VCP project on vaccine trust, funded by the European Commission and pharmaceutical companies among others, aims to identify early signs and causes of public mistrust and tackle them with information campaigns before it is too late.

Larson said headlines referring to Warp Speed – the name of the U.S. operation aimed at delivering a COVID-19 vaccine to the U.S. population by next year – could increase vaccine hesitancy even more than perceptions that the disease could become less lethal.

“One of the most frequent things that comes up in people’s conversations is concerns about how quick it is. If I have to pick one theme that is more recurrent than others it is this one,” Larson said.

Data collected by VCP from social media show that by the end of June about 40% of Britons’ posts concerning a COVID-19 vaccine, for example, were negative, with many distrusting any coronavirus vaccine and the medical establishment.

Announcements about fast progress in COVID vaccines in Russia and China in particular could also contribute to rising scepticism. “We don’t have transparency and don’t know how accurate or valid their data are,” Ratzan said, adding that errors there could boost scepticism elsewhere.

Key for any information campaign to be successful is to tailor it to different audiences as there is no uniform profile of anti-vaxxers, said Kate Elder of Doctors Without Borders, a non-governmental organisation.

“They go from the highly educated to those who don’t believe in science,” she said, urging politicians to be more careful in their messages on vaccines and to better explain the reasons behind potentially fast results against COVID-19.

“We are exploring the idea of a chatbot that will speak in different languages,” said Ratzan, adding it could be something similar to Smokey Bear, the U.S. Forest Service’s campaign to educate about preventing wildfires.

“Different parts of the world will require different strategies. We know we need to tailor it and to be specific,” he said.

Risks are high if hesitancy is not addressed quickly.

During the 2009 swine flu pandemic, growing scepticism about the vaccine led to a failure of the vaccination campaign in France, where only 8% of the population got a shot against the virus which is estimated to have killed around 280,000 people across the world.

A study published in May in the Lancet by a group of French scientists warned of similar risks now in the country where vaccine hesitancy went up from 18% in mid-March when a lockdown was imposed on the French to 26% by the end of that month.

“Distrust is likely to become an issue when the vaccine will be made available,” the scientists concluded.

Reporting by Francesco Guarascio @fraguarascio in Brussels and Josephine Mason in London; Editing by Susan Fenton

Source: – Reuters

Source link

Continue Reading

Health

Indigo Cautious consumer to remain until COVID-19 vaccine

Published

on

TORONTO — Canadian customers likely won’t start frequenting stores for items not on their shopping list until there’s a vaccine for COVID-19, Indigo Books & Music Inc. founder and chief executive said Friday.

“I think our own view is that customers will continue well, well into the months ahead to make shopping an activity they do when they have something specific to buy,” Heather Reisman said during a conference call with analysts. The company released its first-quarter financial results after markets closed Thursday.

Foot traffic is “still way down” for the book retailer, which shuttered all its stores to help stop the spread of the coronavirus and only reopened nearly all 182 of its locations by the end of its most recent quarter.

The Toronto-based company’s revenue for the 13 weeks ended June 27 fell to $135.1 million from $192.6 million due to store closures. It recorded a net loss of about $31.6 million or $1.15 per common share compared with a loss of about $19.1 million or 69 cents per share in the same quarter last year.

Since reopening, retail store sales have tracked at about 72 per cent of sales at the same time last year, said chief financial officer Craig Loudon.

However conversion and average transaction size are both “way up,” noted Reisman.

“So, that’s saying that you’ve got a deliberate customer and we think that that’s going to remain, frankly, until there’s a vaccine.”

In Canada, people watch the news and are afraid of the virus, she said.

“So, all in all, we predict that the retail consumer will remain a cautious consumer,” she said.

The company is working to make the shopping experience easy and safe and is planning for the important holiday shopping season although it remains to be seen how consumers behave during a usually busy period.

The company accelerated efforts during the first quarter to help serve customers safely during the holiday season, including “a robust click-and-collect capability and Instacart service,” said Reisman. These efforts should be implemented in the current quarter.

The company’s e-commerce revenue grew threefold, jumping up 214 per cent for the quarter compared with last year. That demand “has moderated, but remained strong” as stores reopened, said Loudon.

Indigo’s shares, which have plunged from a high of $8.06 last August, surged 19 per cent or 20 cents at $1.25 in afternoon trading on the Toronto Stock Exchange.

This report by The Canadian Press was first published Aug. 7, 2020.

Companies in this story: (TSX:IDG)

The Canadian Press

Source: NewmarketToday.ca

Source link

Continue Reading

Health

Alberta reports 134 new cases of COVID-19 along with 3 more deaths

Published

on

 

Alberta Health reported three additional COVID-19 deaths and 134 new cases, the largest single-day total in over two weeks.

The new cases upsets a recent downward trend, recently praised by the chief medical officer Dr. Deena Hinshaw as a source of collective pride and hard work. The numbers, updated on Friday afternoon, are up-to-date as of the end of Thursday.

The last time Alberta recorded new cases in the triple digits was July 31, when the province detected 101 cases.

According to Friday’s update, there are 1,125 active COVID-19 cases in Alberta. The active-case breakdown by region was

  • Calgary zone: 368
  • Edmonton zone: 329
  • Central zone: 224
  • South zone: 90
  • North zone: 111

While active cases went up, the COVID-19 hospitalization rate continued a downward trend. There are 68 people in hospital, including 18 people in intensive care.

The Good Samaritran Southgate Care Centre, site of the deadliest outbreak in Alberta, reported no new cases of the COVID-19 on Friday. One additional employee had recovered, bringing the total number of recovered cases to 13 staff and 20 residents.

At the centre, 25 residents have died from COVID-19 out of 113 confirmed cases since mid-June.

In all 11,430 people have been diagnosed with COVID-19 in Alberta, of which 208 have died. The number of people who have recovered from the illness has now reached 10,097, according to the update.

Alberta Health Services said it would turn to the private sector to help double its testing capacity and handle asymptomatic tests ahead of September, when daily tests are expected to exceed 20,000 a day, in part because of the return to school.

The province completed 8,533 tests on Thursday. Since the beginning of the pandemic, about one in seven Albertans have been tested

 

Source: – CBC.ca

Source link

Continue Reading

Trending